Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinacalcet in hemodialysis patients with secondary hyperparathyroidism
ACTRN12610000695000Phase 4Completed
- Sponsor
- Kobe University School of Medicine
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of cinacalcet in secondary hyperparathyroidism (SHPT) (2 arms), sponsored by Kobe University School of Medicine. Primary endpoint: Proportion of patients with mean intact parathyroid hormone <180 pg/mL. Started Jan 2008; status: completed.
02
Drugs
cinacalcet
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on ACTRN12610000695000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000695000.